Stock Research for ISRG

ISRG

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ISRG Stock Chart & Research Data

The ISRG chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ISRG chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ISRG Due diligence Resources & Stock Charts

The ISRG stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ISRG Detailed Price Forecast - CNN Money CNN View ISRG Detailed Summary - Google Finance
Yahoo View ISRG Detailed Summary - Yahoo! Finance Zacks View ISRG Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ISRG Trends & Analysis - Trade-Ideas Barrons View ISRG Major Holders - Barrons
NASDAQ View ISRG Call Transcripts - NASDAQ Seeking View ISRG Breaking News & Analysis - Seeking Alpha
Spotlight View ISRG Annual Report - CompanySpotlight.com OTC Report View ISRG OTC Short Report - OTCShortReport.com
TradeKing View ISRG Fundamentals - TradeKing Charts View ISRG SEC Filings - Bar Chart
WSJ View Historical Prices for ISRG - The WSJ Morningstar View Performance/Total Return for ISRG - Morningstar
MarketWatch View the Analyst Estimates for ISRG - MarketWatch CNBC View the Earnings History for ISRG - CNBC
StockMarketWatch View the ISRG Earnings - StockMarketWatch MacroAxis View ISRG Buy or Sell Recommendations - MacroAxis
Bullish View the ISRG Bullish Patterns - American Bulls Short Pains View ISRG Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ISRG Stock Mentions - StockTwits PennyStocks View ISRG Stock Mentions - PennyStockTweets
Twitter View ISRG Stock Mentions - Twitter Invest Hub View ISRG Investment Forum News - Investor Hub
Yahoo View ISRG Stock Mentions - Yahoo! Message Board Seeking Alpha View ISRG Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ISRG - SECform4.com Insider Cow View Insider Transactions for ISRG - Insider Cow
CNBC View ISRG Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ISRG - OTC Markets
Yahoo View Insider Transactions for ISRG - Yahoo! Finance NASDAQ View Institutional Holdings for ISRG - NASDAQ


Stock Charts

FinViz View ISRG Stock Insight & Charts - FinViz.com StockCharts View ISRG Investment Charts - StockCharts.com
BarChart View ISRG Stock Overview & Charts - BarChart Trading View View ISRG User Generated Charts - Trading View




Latest Financial News for ISRG


Gauging Analysts’ Views for NovoCure Stock
Posted on Friday October 19, 2018

Of the five analysts covering NovoCure (NVCR) stock in October, two have given it a “strong buy,” and three have given it a “buy.” The mean rating for NovoCure is 1.6 with a target price of $56.50. That implies an upside potential of 24.4% over its trading price of $45.42 on October 18.


Tech Stocks Rebound As Apple Advances On New Bullish Commentary
Posted on Friday October 19, 2018

Tech stocks rebounded Friday amid a number of strong earnings results. Apple jumped on bullish analyst commentary.


Don't Be Fooled -- Intuitive Surgical Had Another Huge Quarter
Posted on Friday October 19, 2018

One time items aren't a concern. This metric shows growth accelerating


NovoCure’s Operational Performance in Q3 2018: What to Expect
Posted on Friday October 19, 2018

NovoCure’s (NVCR) gross income is expected to rise 28.22% to $44.82 million in the third quarter of 2018. Its gross margin is expected to contract from 69.76% in the third quarter of fiscal 2017 to 68.7% in the third quarter of fiscal 2018. NovoCure’s gross margins for fiscal 2018 and fiscal 2019 are expected to be 67.97% and 72.72%, respectively.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.